Related Experiment Video
Updated: Jul 9, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
Published on: June 4, 2012
Inhibition of telomerase activity in cancer cells using short hairpin RNA expression vectors
Shi-Ming Chen1, Ze-Zhang Tao, Qing-Quan Hua
1Department of Otolaryngology-Head & Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. shimingchen0468@hotmail.com
Abstract:
Telomerase activity is mainly regulated by the human telomerase reverse transcriptase (hTERT) gene. Our objective was to investigate the effect of short hairpin RNA (shRNA) directed against hTERT mRNA on telomerase activity in laryngeal cancer cells (Hep-2), nasopharyngeal carcinoma cells (NEC), and human bone marrow mesenchyme stem cells (hMSCs). Short hairpin RNA expression vectors targeting the messenger RNA of hTERT were constructed. Cells were treated with shRNA expression vectors directed against hTERT mRNA and control vectors that included mismatched shRNA. We found that treatment of special shRNA expression vectors induced significantly decrease in hTERT expression, telomerase activity, and cell viability in Hep-2 and NEC cells. In contrast, the shRNA control showed none of these effects. And none of these effects appeared in hMSCs cells. Our results suggest that shRNA against hTERT mRNA inhibits telomerase activity and cell viability through suppression of the hTERT expression in cancer cells. And this treatment has no side effect on healthy cells lack of telomerase activity. RNA interfering technology may be a promising strategy for the treatment of cancers.
Insights
Short hairpin RNA (shRNA) targeting human telomerase reverse transcriptase (hTERT) mRNA effectively reduced cancer cell viability and telomerase activity. This RNA interference strategy showed no adverse effects on healthy stem cells, indicating its potential for cancer treatment.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Telomerase activity, regulated by the human telomerase reverse transcriptase (hTERT) gene, is crucial for cancer cell proliferation.
- Targeting hTERT offers a potential strategy for cancer therapy by inhibiting telomerase function.
Purpose of the Study:
- To investigate the efficacy of short hairpin RNA (shRNA) targeting hTERT mRNA in reducing telomerase activity and viability in laryngeal and nasopharyngeal cancer cells.
- To assess the safety and specificity of this approach in healthy human bone marrow mesenchyme stem cells (hMSCs).
Main Methods:
- Construction of shRNA expression vectors targeting hTERT mRNA.
- Treatment of laryngeal cancer cells (Hep-2), nasopharyngeal carcinoma cells (NEC), and hMSCs with hTERT-specific shRNA or control vectors.
- Evaluation of hTERT expression, telomerase activity, and cell viability post-treatment.
Main Results:
- shRNA targeting hTERT significantly decreased hTERT expression, telomerase activity, and cell viability in Hep-2 and NEC cells.
- Control vectors did not induce these effects.
- hMSCs, which naturally have low telomerase activity, showed no significant changes in response to the shRNA treatment.
Conclusions:
- shRNA-mediated suppression of hTERT effectively inhibits telomerase activity and cell viability in cancer cells.
- This RNA interference approach demonstrates specificity, sparing healthy cells and suggesting potential as a targeted cancer therapy.
- RNA interference targeting hTERT represents a promising strategy for cancer treatment with minimal side effects on healthy tissues.
More Related Videos
Related Concept Videos
Experimental RNAi
Replicative Cell Senescence
Telomeres and Telomerase
MicroRNAs
MicroRNAs
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...

